Your browser doesn't support javascript.
In South Africa, a 2-dose Oxford/AZ vaccine did not prevent mild to moderate COVID-19 (cases mainly B.1.351 variant).
Irfan, Neal; Chagla, Zain.
  • Irfan N; McMaster University, Hamilton, Ontario, Canada (N.I., Z.C.).
  • Chagla Z; McMaster University, Hamilton, Ontario, Canada (N.I., Z.C.).
Ann Intern Med ; 174(5): JC50, 2021 05.
Article in English | MEDLINE | ID: covidwho-1215695
ABSTRACT
SOURCE CITATION Madhi SA, Baillie V, Cutland CL, et al. Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B.1.351 variant. N Engl J Med. 2021. [Epub ahead of print.] 33725432.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 Topics: Vaccines / Variants Limits: Humans Country/Region as subject: Africa Language: English Journal: Ann Intern Med Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 Topics: Vaccines / Variants Limits: Humans Country/Region as subject: Africa Language: English Journal: Ann Intern Med Year: 2021 Document Type: Article